| Literature DB >> 35017393 |
Giuliano La Barba1, Leonardo Solaini2, Giorgia Radi1, Maria Teresa Mirarchi1, Fabrizio D'Acapito1, Andrea Gardini1, Alessandro Cucchetti2, Giorgio Ercolani2.
Abstract
BACKGROUND: In the last decades, there has been an exponential diffusion of minimally invasive liver surgery (MILS) worldwide. The aim of this study was to evaluate our initial experience of 100 patients undergoing MILS resection comparing their outcomes with the standard open procedures.Entities:
Keywords: Laparoscopic liver resection; minimally invasive surgery; tertiary centre
Year: 2022 PMID: 35017393 PMCID: PMC8830570 DOI: 10.4103/jmas.JMAS_310_20
Source DB: PubMed Journal: J Minim Access Surg ISSN: 1998-3921 Impact factor: 1.407
Figure 1Flowchart summarizing the patients and the propensity score matching
Figure 2Trend of the Minimally Invasive Liver Surgery rate per year
Minimally invasive liver surgery procedures grouped according to the Kawaguchi’s difficulty score
|
| |
|---|---|
| Group 1 (wedge resection and left lateral sectionectomy) | 74 |
| Group 2 (anterolateral segmentectomy and left hepatectomy) | 17 |
| Group 3 (postero-superior segmentectomy, right posterior sectionectomy, right hepatectomy, central hepatectomy, and extended left/right hepatectomy) | 9 |
Patients’ characteristics
| Variables | Total cohort |
| Matched cohort |
| ||
|---|---|---|---|---|---|---|
|
|
| |||||
| MILS ( | Open ( | MILS ( | Open ( | |||
| Age>70 | ||||||
| Yes | 36 (36.0) | 67 (35.2) | 0.898 | 30 (35.3) | 28 (36.9) | 0.868 |
| No | 64 (64.0) | 123 (64.8) | 55 (64.7) | 57 (67.1) | ||
| Female | ||||||
| Yes | 50 (50.0) | 82 (43.1) | 0.321 | 43 (50.6) | 42 (49.4) | 0.753 |
| No | 50 (50.0) | 108 (46.9) | 42 (49.4) | 43 (50.6) | ||
| ASA>2 | ||||||
| Yes | 45 (45.0) | 80 (42.1) | 0.708 | 38 (44.7) | 34 (40.0) | 0.617 |
| No | 55 (55.0) | 110 (67.9) | 47 (55.3) | 51 (60.0) | ||
| Malignancy | ||||||
| Yes | 72 (72.0) | 165 (86.8) | 0.002 | 63 (74.1) | 63 (74.1) | 1.000 |
| No | 28 (28.0) | 25 (13.2) | 22 (25.9) | 22 (25.9) | ||
| Nodules≥3 | ||||||
| Yes | 7 (7.0) | 62 (32.6) | <0.0001 | 6 (7.1) | 8 (9.4) | 1.000 |
| No | 83 (92.2) | 128 (67.4) | 79 (92.9) | 77 (90.6) | ||
| Tumor size (cm) | ||||||
| <2 | 16 (16.0) | 38 (20) | 0.470 | 16 (18.8) | 20 (23.5) | 0.785 |
| ≥2-<5 | 49 (49.0) | 76 (40) | 41 (48.2) | 36 (42.3) | ||
| ≥5 | 31 (31.0) | 56 (29.4) | 28 (32.9) | 29 (34.1) | ||
| NA | 4 (4.0) | 20 (10.6) | ||||
| Neoadjuvant chemotherapy° | ||||||
| Yes | 14 (29.8) | 45 (37.8) | 0.427 | 10 (11.8) | 15 (17.6) | 0.332 |
| No | 33 (70.2) | 74 (62.2) | 75 (88.2) | 70 (82.3) | ||
°Calculated only on metastases (n=47 in MILS vs. 119 in open). MILS: Minimally invasive liver surgery, NA: Not applicable ASA: American Society of Anaesthesiologists
Intra-operative variables
| Variables | Total cohort |
| Matched cohort |
| ||
|---|---|---|---|---|---|---|
|
|
| |||||
| MILS ( | Open ( | MILS ( | Open ( | |||
| Type of procedure | ||||||
| Wedge resection | 47 (47.0) | 96 (50.5) | <0.00001 | 30 (35.3) | 23 (27.1) | 0.067 |
| Segmentectomy | 19 (19.0) | 45 (23.6) | 20 (23.5) | 26 (30.6) | ||
| Right hepatectomy | 5 (5.0) | 15 (7.8) | 5 (5.9) | 8 (9.4) | ||
| Left hepatectomy | 4 (3.0) | 11 (5.7) | 2 (2.3) | 6 (7.1) | ||
| Right posterior sectionectomy | 4 (4.0) | 16 (8.4) | 4 (4.7) | 6 (7.1) | ||
| Left lobectomy | 21 (21.0) | 7 (3.6) | 18 (20.0) | 6 (7.1) | ||
| Conversion to open | ||||||
| Yes | 5 (5) | 5 (5.9) | ||||
| No | 95 (95) | 80 (94.1) | ||||
| Syncronous resection | ||||||
| Right colectomy | 5 (5.0) | 4 (2.1) | 0.097 | 4 (4.7) | 1 (1.2) | 0.581 |
| Left colectomy | 1 (1.0) | 10 (5.2) | 0 | 5 (5.9) | ||
| Anterior rectal resection | 2 (2.0) | 8 (4.2) | 1 (1.2) | 3 (3.6) | ||
| Other | 1 (1.0) | 5 (2.6) | ||||
| Operative time (min) | ||||||
| Median (IQR) | 292 (195-380) | 306 (175-420) | 0.329 | 266 (245-304) | 290 (263-309) | 0.942 |
| Intraoperative blood trasfusion | ||||||
| Yes | 3 (3) | 9 (4.7) | 0.554 | 3 (3.6) | 4 (4.7) | 0.726 |
| No | 97 (97) | 181 (95.3) | 82 (96.7) | 81 (95.3) | ||
MILS: Minimally invasive liver surgery, IQR: Interquartile range
Post-operative outcomes
| Variables | Total cohort | Matched cohort | ||||
|---|---|---|---|---|---|---|
|
|
| |||||
| MILS ( | Open ( |
| MILS ( | Open ( |
| |
| Post-operative complications | ||||||
| Yes | 12 (12.0) | 91 (47.8) | 0.026 | 27 (31.8) | 39 (45.9) | 0.004 |
| No | 88 (88.0) | 99 (52.2) | 58 (69.2) | 46 (54.1) | ||
| Clavien dindo Grade≥3 | ||||||
| Yes | 8 (8.0) | 25 (13.1) | 0.319 | 9 (10.6) | 17 (20) | 0.124 |
| No | 92 (92.0) | 165 (86.9) | 76 (89.4) | 68 (80) | ||
| Mortality | ||||||
| Yes | 0 | 2 (1.1) | 0.546 | 0 | 1 (1.2) | 1.000 |
| No | 100 (100) | 188 (98.9) | 85 (100) | 84 (98.8) | ||
| Post-operative blood transfusion | ||||||
| Yes | 5 (5.0) | 23 (12.1) | 0.060 | 4 (4.7) | 14 (16.5) | 0.021 |
| No | 95 (95.0) | 167 (87.9) | 81 (95.3) | 71 (83.5) | ||
| Ascites | ||||||
| Yes | 2 (2.0) | 11 (5.7) | 0.231 | 2 (2.4) | 7 (8.2) | 0.180 |
| No | 98 (98.0) | 179 (94.3) | 83 (97.6) | 78 (91.8) | ||
| Liver failure | ||||||
| Yes | 0 | 2 (1.0) | 0.545 | 0 | 1 (1.2) | 0.500 |
| No | 100 (100) | 187 (98.4) | 85 (100) | 84 (98.8) | ||
| Subphrenic abscess | ||||||
| Yes | 5 (5.0) | 15 (7.8) | 0.621 | 5 (5.9) | 9 (10.6) | 0.065 |
| No | 85 (85.0) | 174 (92.2) | 80 (94.1) | 76 (89.4) | ||
| Biliary fistula | ||||||
| Yes | 2 (2.0) | 19 (10) | 0.015 | 2 (2.4) | 13 (15.3) | 0.007 |
| No | 98 (98.0) | 170 (90) | 83 (97.6) | 72 (84.7) | ||
| CCI | ||||||
| Median (IQR) | 0 (0-8.7) | 8.7 (0-26.2) | 0.0002 | 0 (0-10.4) | 8.7 (0-28.6) | 0.0009 |
| Length of hospital stay | ||||||
| Median (IQR) | 6 (4-8) | 8 (7-13) | <0.0001 | 6 (5-8) | 8 (7-13) | <0.0001 |
MILS: Minimally invasive liver surgery, IQR: Interquartile range, CCI: Comprehensive complication index